WIZDEE UNDER THE HOOD

whitePaper | November 26, 2019

There has been much said about the Internet of Things (IoT) and what it can bring to business and society - creating a more deeply connected world, informed by data sourced from connected things, made better by smarter, more meaningful actions and interactions. These views often focus on how IoT technical solutions can deliver this new future, emphasizing the technology DNA of IoT devices, networks and applications. We have found, however, both through research and experience, that while technology is, in fact, the core of IoT’s DNA; it is just a piece of the puzzle needed to deliver on IoT’s promise. With 60% of IoT projects still struggling to move out of proof-of-concept and scale successfully2 there is more to IoT success than technology alone. What is needed and how can business leaders plan better for IoT success?

whitePaper | May 26, 2022

Since their invention in 1970 by Edgar Codd, relational databases have served as the default data store for almost every IT organization, large or small. Today, the most iconic and familiar relational databases include IBM DB2, Oracle Database, Microsoft SQL Server, PostgreSQL, and MySQL.

whitePaper | January 27, 2020

AWS maintains a standards-based risk management program to ensure that the HIPAA-eligible services specifically support the administrative, technical, and physical safeguards required under HIPAA. Using these services to store, process, and transmit PHI allows our customers and AWS to address the HIPAA requirements applicable to the AWS utility-based operating model.

whitePaper | May 6, 2022

Every organization today recognizes the strategic value of generating actionable insights from their enterprise data.

whitePaper | May 15, 2023

Genomics is the study of the complete set of DNA in a person or other organism. DNA underpins a large proportion of an individual's health and disease status, therefore a genomic medicine approach is increasingly being applied in clinical settings. Genomic medicine is where the study of clinical outcomes (measurable changes in health and well-being) is combined with genomics so researchers can better understand how a person’s genome contributes to disease. Increasingly, advances in our understanding of the genome are contributing to improvements in disease diagnosis, drug discovery and targeted therapeutics.

whitePaper | January 31, 2020

Many companies have invested heavily in specialized enterprise data warehouses (EDW) and Extract, Transform and Load (ETL) technologies to analyze their operational data. But these technologies were never designed to be truly real-time.They were originally built for batch, and that original design limits how real-timeEDWs and ETL can become. They were also designed to support a focused group ofanalysts, not a larger group of employees spanning operational functions, or even partner and end customers.